[1]
2024. Iron Oxide Nanoparticles Functionalized with Macrocycle Antagonists for CXCR4 Receptor Targeting in Cancer Cells. Journal of Analytical Oncology. 13, (Dec. 2024), 36–42. DOI:https://doi.org/10.30683/1927-7229.2024.13.06.